Pharmacy Benefits/Formulary

 April 30, 2009

As you are aware, we are facing a potential pandemic of swine influenza. You will undoubtedly receive many phone calls requesting prophylactic prescriptions for antiviral medication. In the interest of appropriateness of therapy and ensuring adequate supplies for high risk patients, Sanford Health Plan is initiating a quantity limit on Tamiflu and Relenza. Effective immediately, our members will be limited to one FDA approved treatment course of Tamiflu or Relenza in a six month period. This should be sufficient to provide prophylaxis for exposure or treatment for active disease. You have received guidelines from the CDC for prophylaxis and treatment. I urge you to follow these guidelines and reserve antivirals for those patients who meet CDC criteria.

Thank you for your cooperation in this difficult time.